CHS Reports Third Quarter Fiscal Year 2026 Earnings

CHS INC (CHSCL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a3qfy26earningrelease.htm EX-99.1 Document For further information Contact: Trish Scorpio (651) 355-4593 Patricia.Scorpio@chsinc.com CHS Reports Third Quarter Fiscal Year 2026 Earnings ST. PAUL, MINN. (July 8, 2026) - CHS Inc., a global agribusiness and the nation’s lea

Original reporting
Published Jul 8, 2026, 3:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 8, 2026, 3:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CHSCL
Neutral
medium confidence
Mentioned
$CHSCL
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CHSCLNeutralMed
01

Why it matters

Consolidated net income and revenue increased year over year, supported by energy refining margins and CF Nitrogen equity-method gains, while grains faced margin/transport headwinds and agronomy saw reduced fertilizer sales volumes tied to a weak U.S. farm economy.

02

Market read

Traders can update near-term expectations for CHS based on the latest earnings datapoints and the stated drivers, especially RIN-cost pressure and agronomy volume weakness.

03

What to watch

Segment reclassifications for FY2026 could complicate trend interpretation; also, the CF Nitrogen equity-method performance partially offsets agronomy weakness, so earnings quality may depend on that equity contribution.

Relevance 7/10Novelty 7/10Timing: after-hours earnings release filed on SEC Form 8-K (July 8, 2026)

Background

The 8-K includes Item 2.02 results for CHS’s third quarter of fiscal year 2026 ended May 31, 2026, with segment reporting recast starting FY2026.

Company-level read

Ticker impact

$CHSCLNeutralMedium confidence
Context

CHS reported Q3 FY2026 net income of $267.4M and revenues of $11.6B, with segment drivers including higher refining margins and record RIN costs.

Expected impact

Near-term trading likely hinges on whether investors focus on the consolidated profit rebound versus the RIN-cost and U.S. farm-economy headwinds.

Evidence & confidence

The filing provides fresh, quantified results and segment explanations, but it does not include explicit guidance or a full outlook that would anchor a directional repricing.

Market effects

Read-across to agribusiness and energy refiners on how RIN costs and refining margins are currently balancing earnings.

U.S. farm-economy weakness is cited as pressuring agronomy volumes, which can affect demand expectations for crop inputs.

Global grain margin headwinds and export volume strength are referenced, relevant for commodity-linked earnings sensitivity.

Counterpoint

Investors may discount the profit rebound if they believe RIN costs and grain margin pressure are structural rather than seasonal.

Key entities

  • CHS Inc.

    Global agribusiness and farmer-owned cooperative reporting Q3 FY2026 results on SEC Form 8-K.

  • CF Nitrogen

    Equity-method investment whose favorable urea and UAN market conditions supported agronomy earnings.

  • RINs

    Renewable Identification Numbers costs that were described as record-high and mostly offset energy gains.

Related articles

Med

CHS Reports Fiscal Year 2026 Net Income of $1.1 Billion Energy, Grains and Agronomy Performance Driven by Evolving Market Dynamics; Company Intends to Return…

CHS INC (CHSCL) filed an SEC Form 8-K — Results of Operations and Financial Condition. For further information Contact: Trish Scorpio 651-355-4593 Patricia.Scorpio@chsinc.com CHS Reports Fiscal Year 2026 Net Income of $1.1 Billion Energy, Grains and Agronomy Performance Driven by Evolving Market Dynamics; Company Intends to Return $300 Million Cash to Owners in 202

$SAROMed

StandardAero (SARO) Q3 2026 Earnings Call Transcript

StandardAero reported Q3 2026 earnings with 30% year-over-year adjusted EPS growth, 15% adjusted EBITDA growth, and a 130 basis points adjusted EBITDA margin expansion to 14.4%. Revenue grew across commercial aerospace, business aviation, and military & helicopter sectors. The company highlighted strong demand visibility and strategic investments driving long-term growth.

$PCTYHighAI 8/10

Paylocity (PCTY) Q1 2027 Earnings Call Transcript

Paylocity (PCTY) reported Q1 2027 recurring revenue of $424.5M, up 12% YoY, and total revenue of $451.7M, up 11%. The company launched Recruiting Optimizer, an AI-driven tool that improved recruiting productivity by 35% and filled roles 25% faster. Paylocity raised fiscal 2027 guidance and repurchased 1.1M shares at $139 each. The company highlighted strong client adoption of its AI platform and received industry recognitions.

$AHRHighAI 8/10

Healthcare REIT (AHR) Q3 2026 Earnings Call Transcript

American Healthcare REIT (AHR) reported Q3 2026 earnings with same-store NOI growth of 13.8%, raising full-year NFFO per diluted share growth guidance to over 30%. The company completed $2.1B in investments and has a $1B pipeline, while maintaining a net debt to EBITDA ratio of 1.9x. AHR emphasized its strategy of organic growth, accretive investments, and balance sheet management.

$MGYMedAI 8/10

Magnolia Oil & Gas Q3 Earnings Call Highlights

Magnolia Oil & Gas (MGY) reported Q3 earnings, targeting 65% of 2027 drilling in Austin Chalk. Net debt reduced to $1.9B, below 1x 2027 EBITDAX. Repurchased $60M in shares, increased authorization by 15M shares. Q4 production forecasted at 159K-161K BOE/d. 2027 budget set at $900M-$950M, with 4-5% growth expected. Sold non-core assets for $47.5M.